PE anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_PE_090808.jpg
C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
  • 1A8_PE_090808.jpg
    C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
127607 50 µg 108€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127608 200 µg 227€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  2. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  3. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  4. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  5. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  6. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  7. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  8. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  9. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  10. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  11. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  12. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  13. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  14. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  15. Volmari A, et al. 2021. Hepatol Commun. 5:2104. PubMed
  16. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  17. Jung J, et al. 2019. Cell Host Microbe. 25:513. PubMed
  18. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  19. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  20. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  21. Cai B, et al. 2016. Proc Natl Acad Sci U S A. 113: 6526 - 6531. PubMed
  22. Kozik J, et al. 2016. Sci Rep. 6:28556. PubMed
  23. Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed
  24. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  25. Gawish R, et al. 2022. Elife. 11:. PubMed
  26. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  27. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  28. Ancey PB, et al. 2021. Cancer Res. 81:2345. PubMed
  29. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  30. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  31. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  32. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  33. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  34. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  35. Putnam NE, et al. 2019. PLoS Pathog. 15:e1007744. PubMed
  36. Ajendra J, et al. 2016. Sci Rep. 6:39648. PubMed
  37. Bottek J, et al. 2020. Mucosal Immunol. 1.029166667. PubMed
  38. Sharma K, et al. 2021. Cell Reports. 36(3):109351. PubMed
  39. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  40. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  41. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  42. Ishii T,et al. 2017. Sci Rep.. 10.1038/s41598-017-12513-1. PubMed
  43. Xie D, et al. 2017. PLoS One. 10.1371/journal.pone.0181454. PubMed
  44. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  45. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  46. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  47. Sun P, et al. 2015. J Hepatol. . PubMed
  48. Okada M, et al. 2014. J Biol Chem. 289:32926. PubMed
  49. Muhammad W, et al. 2022. Acta Biomater. 148:258. PubMed
  50. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  51. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  52. Harding M, et al. 2014. PLoS Pathog. 10:1004379. PubMed
  53. Morales D, et al. 2015. J Virol. 89:337. PubMed
  54. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  55. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  56. Yeo WS, et al. 2020. J Bacteriol. 202:00:00. PubMed
  57. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  58. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  59. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  60. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  61. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  62. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  63. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  64. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  65. Lemon J, et al. 2015. Infect Immun . 83: 3204-3212. PubMed
  66. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  67. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  68. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  69. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  70. Schaffert A, et al. 2020. Front Immunol. 10:3024. PubMed
  71. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  72. Metzger D, et al. 2015. J Infect Dis. 212: 445-452. PubMed
  73. Winkler MJ, et al. 2020. Basic Res Cardiol. 115:67. PubMed
  74. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  75. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  76. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  77. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  78. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  79. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  80. Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed
  81. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  82. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  83. McLaughlin PA et al. 2019. PLoS Pathog. 15(7):e1007847 . PubMed
  84. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  85. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  86. Kojo K, et al. 2016. Sci Rep. 6:29650. PubMed
  87. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  88. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  89. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  90. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  91. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  92. Markman JL, et al. 2020. Nat Commun. 11:1613. PubMed
  93. Wheeler MA, et al. 2019. Cell. 176:581. PubMed
  94. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  95. Catani J, et al. 2016. Transl Oncol. 9:565-574. PubMed
  96. Zhou Z, et al. 2022. Life (Basel). 12:. PubMed
  97. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  98. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  99. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  100. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  101. Umeshappa CS, et al. 2021. Cell Reports. 34(13):108919. PubMed
  102. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  103. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  104. Su M, et al. 2022. Nat Cardiovasc Res. 1:732. PubMed
  105. Kim Y, et al. 2012. J Immunol. 188:4226. PubMed
  106. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  107. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  108. Unudurthi SD, et al. 2020. Life Sci. 117440:247. PubMed
  109. Finsterbusch M, et al. 2014. J Exp Med. 211:1307. PubMed
  110. Vergadi E, et al. 2014. J Immunol. 192:394. PubMed
  111. Rynkiewicz NK, et al. 2020. Sci Signal. 13:. PubMed
  112. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  113. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  114. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  115. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  116. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  117. Kimura H, et al. 2019. Sci Rep. 9:5887. PubMed
  118. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  119. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  120. Bronisz–Budzynska I, et al. 2019. Skelet Muscle. 9:22. PubMed
  121. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  122. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  123. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  124. Takizawa S, et al. 2022. Mol Med. 28:91. PubMed
  125. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  126. Kim M, et al. 2018. Immunity. 49:151. PubMed
  127. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  128. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  129. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  130. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  131. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  132. Murray MP, et al. 2022. Cell Rep. 38:110209. PubMed
  133. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  134. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  135. Penke LR, et al. 2020. Life Sci Alliance. 3:. PubMed
  136. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  137. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  138. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  139. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  140. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  141. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  142. Eislmayr K, et al. 2022. Sci Adv. 8:eabj7293. PubMed
  143. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  144. Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed
  145. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  146. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  147. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  148. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  149. Huang W, et al. 2016. Cell Death Differ. 10.1038/cdd.2016.115. PubMed
  150. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  151. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  152. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  153. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  154. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  155. Issah Y, et al. 2021. Elife. 10:. PubMed
  156. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  157. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  158. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  159. Weckbach LT, et al. 2019. J Exp Med. 216:350. PubMed
  160. Kimura T, et al. 2014. Int Immunol. 26:697. PubMed
  161. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  162. Hu R, et al. 2015. J Immunol. 195: 4802 - 4809. PubMed
  163. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  164. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  165. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  166. Subramaniam N, et al. 2021. Blood Adv. 5:1259. PubMed
  167. Li Y, et al. 2022. Theranostics. 12:5364. PubMed
  168. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  169. Li Y, et al. 2020. Theranostics. 10:11376. PubMed
  170. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  171. Moraes JA, et al. 2018. J Innate Immun. 11:330. PubMed
  172. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  173. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  174. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  175. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  176. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  177. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  178. Guo H, et al. 2016. J Immunol. 196: 2300 - 2308. PubMed
  179. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  180. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  181. Wang C, et al. 2020. Mucosal Immunol. 13:22. PubMed
  182. Hou Y, et al. 2013. J Nutr Biochem. 24:1555. PubMed
  183. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  184. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  185. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  186. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  187. Schuran FA, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  188. Wheeler MA, et al. 2020. Nature. 578:593. PubMed
  189. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  190. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  191. Zha ZX, et al. 2022. Acta Pharmacol Sin. :. PubMed
  192. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  193. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  194. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  195. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  196. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  197. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  198. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  199. Rodgers M, et al. 2014. J Exp Med. 211:1333. PubMed
  200. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  201. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
RRID
AB_1186104 (BioLegend Cat. No. 127607)
AB_1186099 (BioLegend Cat. No. 127608)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Go To Top Version: 3    Revision Date: 01.06.2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account